MXI1 Antibody / Max-interacting protein 1 / BHLHC11, Clone: [PCRP-MXI1-1A3], Mouse, Monoclonal

Artikelnummer: NSJ-V9204-100UG
Artikelname: MXI1 Antibody / Max-interacting protein 1 / BHLHC11, Clone: [PCRP-MXI1-1A3], Mouse, Monoclonal
Artikelnummer: NSJ-V9204-100UG
Hersteller Artikelnummer: V9204-100UG
Alternativnummer: NSJ-V9204-100UG
Hersteller: NSJ Bioreagents
Wirt: Mouse
Kategorie: Antikörper
Applikation: FACS, IF, WB
Spezies Reaktivität: Human
Immunogen: Recombinant full-length human MXI1 protein was used as the immunogen for the MXI1 antibody.
It is now well established that Myc regulation of cell proliferation and differentiation involves a family of related transcription factors. One such factor, Max, is an obligate heterodimeric partner for Myc and can also form heterodimers with at least four related proteins designated Mad 1, Mxi1 (also designated Mad 2), Mad 3 and Mad 4. Like Mad 1 and Mxi1, association of Mad 3 and Mad 4 with Max results in transcriptional repression. Both Myc and the Mad proteins have short half-lives and their synthesis is tightly regulated, while Max expression is constitutive and relatively stable. Two related mammalian cDNAs have been identified and shown to encode Mad- binding proteins. Both possess sequence homology with the yeast transcription repressor Sin3 including four conserved paired amphipathic helix (PAH) domains. mSin3A and mSin3B specifically interact with the Mad proteins via their second paired amphipathic helix domain (PAH2). It has been suggested that Mad-Max heterodimers repress transcription by tethering mSin3 to DNA as corepressors.
Klonalität: Monoclonal
Klon-Bezeichnung: [PCRP-MXI1-1A3]
UniProt: P50539
Reinheit: Protein A/G affinity
Formulierung: 0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced), 0.05% sodium azide
Antibody Type: Primary Antibody
Application Verdünnung: Flow cytometry: 1-2ug/million cells,Immunofluorescence: 1-2ug/ml,Western blot: 1-2ug/ml
Anwendungsbeschreibung: Optimal dilution of the MXI1 antibody should be determined by the researcher.